Newsroom
Sorted by: Latest
-
MBP Global Appoints Jatinder Singh as Tax Partner to Strengthen Cross-Border Tax Capabilities
NEW YORK--(BUSINESS WIRE)--MBP Global LLP is pleased to announce that Jatinder Singh will join the firm as a Tax Partner, effective April 15, 2026. Her appointment further enhances the firm’s capabilities in delivering sophisticated tax solutions to clients navigating complex U.S. and international regulatory environments. Jatinder brings extensive experience in U.S. inbound taxation, cross-border treaty planning, and the taxation of foreign entities, along with deep expertise in multi-state ne...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 14.04.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,384,198.91 27.683 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 14.04.2026 FTEG.LN IE0009F7UB30 125,002.00 EUR 2,624,461.04 20.995 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 14.04.2026 MSEP.LN IE0009DRFET8 50,002.00 USD 1,366,386.98 27.327 ...
-
Viant Announces Agreement to Acquire TVision Strengthening Its AI-Powered Programmatic Platform
IRVINE, Calif.--(BUSINESS WIRE)--Viant Technology today announced it has entered into a definitive agreement to acquire TVision Insights....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 14.04.2026 RDVY LN IE000K5F6EL4 875,002.00 USD 20,403,469.98 23.318 ...
-
World Kinect Corporation to Host First Quarter 2026 Earnings Conference Call on April 23, 2026
MIAMI--(BUSINESS WIRE)--World Kinect Corporation (NYSE: WKC) invites you to participate in a conference call with its management team on Thursday, April 23, 2026, at 5:00 p.m. ET to discuss the company's first quarter 2026 results, as well as certain forward-looking information. The company plans to release its first quarter 2026 results after the market closes on the same date. Participants can access the live webcast by visiting the company’s website at ir.world-kinect.com/events. An on-deman...
-
Owens Corning to Announce First-Quarter Financial Results on May 6
TOLEDO, Ohio--(BUSINESS WIRE)--Owens Corning (NYSE: OC), a building products leader, is scheduled to announce its first-quarter financial results on Wednesday, May 6, 2026, before the New York Stock Exchange opens. The company will host a call to discuss its financial results at 9 a.m. ET the same day. Webcast https://events.q4inc.com/attendee/708832778 A webcast replay will be available for one year using the same link. Callers Please dial in 10-15 minutes before the conference call is schedul...
-
U.S. Physical Therapy Announces $450 Million Credit Facility
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced the closing of a $450 million, five-year credit facility that includes a $175 million term loan and a $275 million revolver with a maturity date of April 14, 2031. Based on strong lender support, the credit facility was upsized from its initial $400 million launc...
-
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
JERSEY CITY, N.J.--(BUSINESS WIRE)--VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD....